Axinn Expands IP and Regulatory Practice with Partner Aziz Burgy
December 16, 2015
Axinn is pleased to announce that Aziz Burgy has joined the firm as a partner in the IP Group. Mr. Burgy, who will be based in Axinn’s Washington, DC office, previously practiced as a partner at Arent Fox LLP.
"We are excited to have Aziz,” said Managing Partner James Veltrop. “He is a highly-regarded attorney who understands the need to harmonize litigation, regulatory, and business strategies. His skills in handling complex matters and his deep knowledge of the life sciences industry perfectly complement the areas in which our firm has become a recognized leader."
Mr. Burgy has over a dozen years of patent litigation experience, including over 30 pharmaceutical and medical device cases. He also has extensive experience litigating before the U.S. Patent & Trademark Office. Mr. Burgy has tried other types of patent cases in U.S. district courts and before the International Trade Commission, including those involving medical devices, Internet security, robotics, software, and GPS technology.
Mr. Burgy earned his J.D. at the University of New Hampshire School of Law and holds a Master of Biotechnology from Johns Hopkins University. Prior to attending law school, he worked at MedImmune, Inc.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
IBA Annual Conference 2025
Speaking Engagement
Antitrust
Thomson Reuters 24th Annual Law Firm COO & CFO Forum
Speaking Engagement
LegalNEXT 2025
Speaking Engagement
Antitrust
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
Antitrust 101: Trial-Minded Antitrust Discovery
Webinar
Antitrust
ABA Antitrust Plaintiffs' Roundtable 2025
Speaking Engagement
Antitrust
Centerforce IP Strategy Summit: Palo Alto
Speaking Engagement
Intellectual Property
Corporate Counsel Women, Influence, & Power in Law Conference 2025
Speaking Engagement
Antitrust